These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 25041838
1. Expression of focal adhesion kinase in uveal melanoma and the effects of Hsp90 inhibition by 17-AAG. Faingold D, Filho VB, Fernandes B, Jagan L, de Barros AM, Orellana ME, Antecka E, Burnier MN. Pathol Res Pract; 2014 Nov; 210(11):739-45. PubMed ID: 25041838 [Abstract] [Full Text] [Related]
2. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines. Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F. Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615 [Abstract] [Full Text] [Related]
5. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression. Georgakis GV, Li Y, Rassidakis GZ, Medeiros LJ, Younes A. Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164 [Abstract] [Full Text] [Related]
6. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW. Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143 [Abstract] [Full Text] [Related]
7. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts. Schwock J, Dhani N, Cao MP, Zheng J, Clarkson R, Radulovich N, Navab R, Horn LC, Hedley DW. Cancer Res; 2009 Jun 01; 69(11):4750-9. PubMed ID: 19458065 [Abstract] [Full Text] [Related]
8. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells. Liu X, Ban LL, Luo G, Li ZY, Li YF, Zhou YC, Wang XC, Jin CG, Ye JG, Ma DD, Xie Q, Huang YG. Anticancer Drugs; 2016 Jun 01; 27(5):417-26. PubMed ID: 26872308 [Abstract] [Full Text] [Related]
9. Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Martins CM, Fernandes BF, Antecka E, Di Cesare S, Mansure JJ, Marshall JC, Burnier MN. Eye (Lond); 2008 May 01; 22(5):707-11. PubMed ID: 18219339 [Abstract] [Full Text] [Related]
10. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ. Laryngoscope; 2003 Nov 01; 113(11):1944-8. PubMed ID: 14603053 [Abstract] [Full Text] [Related]
11. NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG. Kasai S, Arakawa N, Okubo A, Shigeeda W, Yasuhira S, Masuda T, Akasaka T, Shibazaki M, Maesawa C. PLoS One; 2016 Nov 01; 11(4):e0153181. PubMed ID: 27045471 [Abstract] [Full Text] [Related]
12. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel. Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB. Cancer Res; 2008 Jan 15; 68(2):589-96. PubMed ID: 18199556 [Abstract] [Full Text] [Related]
13. A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK. Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter JA, König GM, Maggiolini M, Kostenis E, Schlaepfer DD, Tamayo P, Chen Q, Ruppin E, Gutkind JS. Cancer Cell; 2019 Mar 18; 35(3):457-472.e5. PubMed ID: 30773340 [Abstract] [Full Text] [Related]
14. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Kurashina R, Ohyashiki JH, Kobayashi C, Hamamura R, Zhang Y, Hirano T, Ohyashiki K. Cancer Lett; 2009 Oct 18; 284(1):62-70. PubMed ID: 19464103 [Abstract] [Full Text] [Related]
15. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A. Clin Cancer Res; 2006 Jan 15; 12(2):584-90. PubMed ID: 16428504 [Abstract] [Full Text] [Related]
16. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer. Roy-Luzarraga M, Abdel-Fatah T, Reynolds LE, Clear A, Taylor JG, Gribben JG, Chan S, Jones L, Hodivala-Dilke K. JAMA Netw Open; 2020 Oct 01; 3(10):e2019304. PubMed ID: 33107920 [Abstract] [Full Text] [Related]
18. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG. Liu H, Zhang T, Chen R, McConkey DJ, Ward JF, Curley SA. J Surg Res; 2012 Jul 01; 176(1):147-53. PubMed ID: 22099584 [Abstract] [Full Text] [Related]